Latest news
Jennifer Taubert announces retirement from J&J; Takeda’s global TYK2 leader exits - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 11:00:00 GMTJ&J (JNJ) Innovative Medicine Chair Jennifer Taubert Retires After 21 Years As Tom Cavanaugh Takes The Helm - londoninsider.co.uklondoninsider.co.uk · Wed, 05 Aug 2026 11:53:17 GMTCavanaugh to replace Taubert as J&J's pharma head - pharmaphorumpharmaphorum · Wed, 05 Aug 2026 11:38:09 GMTTom Cavanaugh Appointed Head of J&J Innovative Medicine - Healthcare DigitalHealthcare Digital · Wed, 05 Aug 2026 10:34:59 GMTJohnson & Johnson (JNJ) Could Be 10% Overvalued Following Leadership Change - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 06:10:22 GMTJohnson & Johnson (JNJ) Announces Retirement of Innovative Medic - GuruFocusGuruFocus · Tue, 04 Aug 2026 15:56:21 GMTJohnson & Johnson EVP Jennifer Taubert to Retire, Tom Cavanaugh Named Successor - Contract PharmaContract Pharma · Tue, 04 Aug 2026 15:36:10 GMTJ&J innovative medicine chief Jennifer Taubert to retire, handing reins to North America head - Fierce PharmaFierce Pharma · Tue, 04 Aug 2026 14:55:17 GMT